IntelGenx Technologies (IGXT) Rating Increased to Hold at ValuEngine

IntelGenx Technologies (OTCMKTS:IGXT) was upgraded by research analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Monday.

Several other equities analysts have also recently issued reports on the company. Aegis reiterated a “buy” rating on shares of IntelGenx Technologies in a research report on Monday, January 29th. Zacks Investment Research upgraded IntelGenx Technologies from a “sell” rating to a “hold” rating in a research report on Wednesday, February 7th. Finally, HC Wainwright set a $2.00 price target on IntelGenx Technologies and gave the company a “buy” rating in a research report on Wednesday, December 6th.

How to Become a New Pot Stock Millionaire

Shares of IGXT stock traded down $0.01 during mid-day trading on Monday, hitting $0.70. 132,664 shares of the stock traded hands, compared to its average volume of 86,766. IntelGenx Technologies has a twelve month low of $0.60 and a twelve month high of $1.09. The stock has a market cap of $47.41, a PE ratio of -17.38 and a beta of 0.70. The company has a debt-to-equity ratio of 1.53, a quick ratio of 2.65 and a current ratio of 2.65.

TRADEMARK VIOLATION WARNING: This story was originally posted by WKRB News and is the sole property of of WKRB News. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at

About IntelGenx Technologies

IntelGenx Technologies Corp. is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets.

Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with's FREE daily email newsletter.

Leave a Reply